Evidence map›Paper›PMID 27019227›Full record

ArticleNature immunology2016

DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.

Petro Starokadomskyy, Terry Gemelli, Jonathan J Rios, Chao Xing, Richard C Wang, Haiying Li, Vladislav Pokatayev, Igor Dozmorov, Shaheen Khan, Naoteru Miyata and 21 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 153 citations in OpenAlex.

  1. A Systematic Review of Monogenic Inflammatory Bowel Disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Role of DEAD/DEAH-box helicases in immunity, infection and cancers.Cell communication and signaling : CCS · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Nsp1 stalls DNA Polymerase α at DNA hairpins.bioRxiv : the preprint server for biology · 2024
    Article
  14. Article
  15. Utilization of next-generation sequencing to define the role of heterozygousThe journal of allergy and clinical immunology. Global · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 13 institutions in 7 countries.

Petro StarokadomskyyDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Terry GemelliEugene McDermott Center for Human Growth &Development, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Jonathan J RiosEugene McDermott Center for Human Growth &Development, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Chao XingEugene McDermott Center for Human Growth &Development, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Richard C WangDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Haiying LiDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Vladislav PokatayevDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Igor DozmorovDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Shaheen KhanDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Naoteru MiyataDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Guadalupe FraileDepartment of Internal Medicine, Ramón y Cajal University Hospital, Madrid, Spain.
Prithvi RajDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Zhe XuDepartment of Dermatology, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Zigang XuDepartment of Dermatology, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Lin MaDepartment of Dermatology, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Zhimiao LinDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Huijun WangDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Yong YangDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Dan Ben-AmitaiUnit of Pediatric Dermatology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Naama OrensteinGenetics Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Huda MussaffiSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eulalia BaselgaDepartment of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Gianluca TadiniPediatric Dermatology Unit and Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Eyal GrunebaumDevelopmental &Stem Cell Biology Program, Hospital for Sick Children, Toronto, Canada.
Adrijan SarajlijaMother and Child Health Care Institute of Serbia, Belgrade, Serbia.
Konrad KrzewskiLaboratory of Immunogenetics, Receptor Cell Biology Section, NIAID, NIH, Rockville, Maryland, USA.
Edward K WakelandDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Nan YanDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Maria Teresa de la MorenaDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Andrew R ZinnDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID http://orcid.org/0000-0002-4935-3291
Ezra BursteinDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
The University of Texas Southwestern Medical Center · USCapital Medical University · CNPeking University · CNSouthwestern Medical Center · USTel Aviv University · ILHospital de Sant Pau · ESHospital for Sick Children · CAInstituto Cajal · ESNational Institutes of Health · USSchneider Children's Medical Center · ILTexas Scottish Rite Hospital for Children · USUniversity of Belgrade · RSUniversity of Milan · IT

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MELANIE H. COBB · 2010 to 2026
$53.7M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
INTEGRATIVE IMMUNOLOGY TRAINING PROGRAMT32AI005284 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Nan Yan · 2003 to 2026
$7.4M
Role of the CCC complex in immune functionR01DK073639 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI BURSTEIN, EZRA · 2007 to 2020
$3.7M
HIV Subversion of Innate ImmunityR01AI098569 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI YAN, NAN · 2012 to 2016
$2.1M
Elucidating the Role of Akt and Keratins in Autophagy and TumorigenesisK08CA164047 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WANG, RICHARD C · 2012 to 2016
$708k
NF-kB Signaling Insights from a Rare X-linked Immunodeficiency SyndromeR56AI113274 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI BURSTEIN, EZRA, ZINN, ANDREW R. · 2014 to 2014
$398k
NCATS NIH HHS UL1 TR001105NCATS NIH HHS UL1TR001105NCI NIH HHS K08 CA164047NCI NIH HHS P30 CA142543NCI NIH HHS P30CA142543NIAID NIH HHS R01 AI098569NIAID NIH HHS R01AI098569NIAID NIH HHS R56 AI113274NIAID NIH HHS R56AI113274NIAID NIH HHS T32 AI005284NIAID NIH HHS T32AI005284NIDDK NIH HHS R01 DK073639NIDDK NIH HHS R01DK073639
6 · The paper itself

Abstract

Aberrant nucleic acids generated during viral replication are the main trigger for antiviral immunity, and mutations that disrupt nucleic acid metabolism can lead to autoinflammatory disorders. Here we investigated the etiology of X-linked reticulate pigmentary disorder (XLPDR), a primary immunodeficiency with autoinflammatory features. We discovered that XLPDR is caused by an intronic mutation that disrupts the expression of POLA1, which encodes the catalytic subunit of DNA polymerase-α. Unexpectedly, POLA1 deficiency resulted in increased production of type I interferons. This enzyme is necessary for the synthesis of RNA:DNA primers during DNA replication and, strikingly, we found that POLA1 is also required for the synthesis of cytosolic RNA:DNA, which directly modulates interferon activation. Together this work identifies POLA1 as a critical regulator of the type I interferon response.

Indexed as

Base SequenceCells, CulturedCytosolDNADNA Polymerase IFamily HealthFemaleFibroblastsGene Expression ProfilingGenetic Diseases, X-LinkedHEK293 CellsHeLa CellsHumansImmunoblottingInterferon Type IMaleDNADNA Polymerase IInterferon Type IRNA

Identifiers

PMID27019227
PMCPMC4836962
OpenAlexW2325608780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.